Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07600671
Eating Disorder Dynamic InterventionNational Institutes of Health (NIH)Not Yet RecruitingNot Applicable
NCT07600671Not Yet Recruiting
Not Applicable
Eating Disorder Dynamic InterventionNational Institutes of He...
NCT07603375
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal AdenocarcinomaDuke UniversityNot Yet RecruitingPhase 2
NCT07603375Not Yet Recruiting
Phase 2
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Lo...Duke University
NCT07604454
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of LahoreCompletedNot Applicable
NCT07604454Completed
Not Applicable
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of Lahore
NCT07602179
Analgesic Efficacy and Hemodynamic Stability of Ultrasound-guided Thoracic Erector Spinae Plane Block Versus Thoracic Epidural Analgesia in Pediatric Thoracic Surgery: a Randomized Controlled Trial.Nguyen Dang ThuCompletedNot Applicable
NCT07602179Completed
Not Applicable
Analgesic Efficacy and Hemodynamic Stability of Ultrasound-guided Thoracic Erect...Nguyen Dang Thu
NCT07605182
Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal AgeAndrology and Fertility Hospital of HanoiNot Yet RecruitingNot Applicable
NCT07605182Not Yet Recruiting
Not Applicable
Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Pa...Andrology and Fertility H...
NCT07603128
Multicenter Validation of a Risk Prediction Model for MDRGNB InfectionRuijin HospitalNot Yet Recruiting
NCT07603128Not Yet Recruiting
—
Multicenter Validation of a Risk Prediction Model for MDRGNB InfectionRuijin Hospital
NCT07604909
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyFudan UniversityRecruitingPhase 2
NCT07604909Recruiting
Phase 2
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Thera...Fudan University
NCT07601295
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)National Heart, Lung, and Blood Institute (NHLBI)Not Yet RecruitingPhase 2
NCT07601295Not Yet Recruiting
Phase 2
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of P...National Heart, Lung, and...
NCT07605338
To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis.Colgate PalmoliveActive Not RecruitingPhase 3
NCT07605338Active Not Recruiting
Phase 3
To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established...Colgate Palmolive
NCT07604571
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast CancerNovartis PharmaceuticalsNot Yet RecruitingPhase 1
NCT07604571Not Yet Recruiting
Phase 1
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/...Novartis Pharmaceuticals
NCT07603037
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory FailureFirst Affiliated Hospital of Wannan Medical CollegeNot Yet RecruitingNot Applicable
NCT07603037Not Yet Recruiting
Not Applicable
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion...First Affiliated Hospital...
NCT07601269
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.RecruitingEarly Phase 1
NCT07601269Recruiting
Early Phase 1
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.
NCT07605312
AI-Based Risk Prediction Model for Upper Digestive Tract CancerNational Taiwan University HospitalNot Yet Recruiting
NCT07605312Not Yet Recruiting
—
AI-Based Risk Prediction Model for Upper Digestive Tract CancerNational Taiwan Universit...
NCT07602647
Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Undergoing Elective Inguinal Hernia RepairFudan UniversityNot Yet Recruiting
NCT07602647Not Yet Recruiting
—
Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Unde...Fudan University
NCT07602608
Platelet-Rich Plasma With or Without Tadalafil for Erectile DysfunctionBenha UniversityCompletedPhase 4
NCT07602608Completed
Phase 4
Platelet-Rich Plasma With or Without Tadalafil for Erectile DysfunctionBenha University
NCT07603843
Use of Cognitive Aid Methods in the Management of Status EpilepticusAnkara UniversityNot Yet RecruitingNot Applicable
NCT07603843Not Yet Recruiting
Not Applicable
Use of Cognitive Aid Methods in the Management of Status EpilepticusAnkara University
NCT07601490
The Effect of Nerve Blocks on Analgesia in Breast Cancer SurgerySultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyNot Yet RecruitingNot Applicable
NCT07601490Not Yet Recruiting
Not Applicable
The Effect of Nerve Blocks on Analgesia in Breast Cancer SurgerySultan Abdulhamid Han Tra...
NCT07604766
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaGenmabNot Yet RecruitingPhase 3
NCT07604766Not Yet Recruiting
Phase 3
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Inv...Genmab
NCT07604961
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPDMehmet İsmail TOSUNCompletedNot Applicable
NCT07604961Completed
Not Applicable
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPDMehmet İsmail TOSUN
NCT07603700
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary EmbolismNanjing First Hospital, Nanjing Medical UniversityNot Yet Recruiting
NCT07603700Not Yet Recruiting
—
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonar...Nanjing First Hospital, N...
Result Breakdown
Not yet recruiting13 (65%)
Completed4 (20%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 32 (10%)
Phase 11 (5%)
Early Phase 11 (5%)
Phase 41 (5%)